
|Articles|September 10, 2014
New England Independent Review Board Joins the WIRB-Copernicus Group
WIRB-Copernicus Group announced that New England Independent Review Board has joined its group of companies.
Advertisement
WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced that New England Independent Review Board (IRB) has joined its group of companies. Based near Boston, MA, New England IRB expands WCG’s presence in the important New England clinical research hub and further increases its expertise in all phases of drug, medical device and behavioral research. Founded in 1988, New England IRB was one of the first national, central IRBs dedicated to ensuring the rights and welfare of research study participants.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Organizational Barriers to Programmatic Recruitment, Scaling Selective Safety Data Collection, and Subcutaneous Alzheimer's Treatment
2
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
3
ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy
4
Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma
5




